Risk of Mortality among Patients with Gastrointestinal Bleeding with Early and Late Treatment with Tranexamic Acid: A Population-Based Cohort Study

Tranexamic acid (TXA) is an antifibrinolytic pharmacological agent, but its use in gastrointestinal bleeding remains contentious. Moreover, studies on the timing of TXA administration are limited. We examined whether early TXA administration reduced the risk of mortality in patients with gastrointes...

Descripción completa

Detalles Bibliográficos
Autores principales: Ting, Ke-Hsin, Shiu, Bei-Hao, Yang, Shun-Fa, Liao, Pei-Lun, Huang, Jing-Yang, Chen, Yin-Yang, Yeh, Chao-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951209/
https://www.ncbi.nlm.nih.gov/pubmed/35330064
http://dx.doi.org/10.3390/jcm11061741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951209/
https://www.ncbi.nlm.nih.gov/pubmed/35330064
http://dx.doi.org/10.3390/jcm11061741

Ejemplares similares